top of page
ECTRIMS Pre-Day 2024
This exploratory day ahead of the annual ECTRIMS meeting targeted specialised topics in multiple sclerosis and related neuroinflammatory autoimmune diseases.
​
ECTRIMS Pre-Day aims to catalyse collaboration, forge connections, and provide the support each specialised group deserves.
_QWB2628.jpg

Sessions

Presentations on Paediatric MS, NMOSD/MOGAD and Encephalitis

Chairpersons:

  • Josep Dalmau (Barcelona, ES)

  • Brenda Banwell (Philadelphia, US)

  • Jacqueline Palace (Oxford, UK)

Speakers:

  • Giulia Fadda (Ottawa, CA)

  • Soumya Yandamuri (Yale, US)

  • Frank Leypoldt (Kiel, DE)

  • Romana Höftberger (Vienna, AT)

Antibodies assays: measuring and pathogenesis. 

Chairpersons:

  • Sara Mariotto (Verona, IT)

  • Sean Pittock (Rochester, US)

  • Romain Marignier (Lyon, FR)

Speakers:

  • Marianna Spatola (Barcelona, ES)

  • Patrick Waters (Oxford, UK)

Cognitive consequences of pediatric MS, the challenges of diagnosing seronegative autoimmune encephalitis, innovative treatments in NMOSD/MOGAD, and the neurological complications of immune checkpoint inhibitors.

Chairpersons:

  • Michael Yeaman (UCLA, US)

  • Thaïs Armangué (Barcelona, ES)

  • Bruno Stankoff (Paris, FR)

Speakers:

  • Maria Pia Amato (Florence, IT)

  • Maarten Titulaer (Rotterdam, NL)

  • Scott Zamvil (UCSF, US)

  • Jerome Honorat (Lyon, FR)

Novel trial design in rare diseases (Clinical session)

Chairpersons:

  • Maria Pia Sormani (Genoa, IT)

  • Friedemann Paul (Berlin, DE)

  • Maarten Titulaer (Rotterdam, NL)

Speakers:

  • Ruth Geraldes (Oxford, UK)

  • Barbara Kornek (Vienna, AT)

ABOUT US 

MEDEN is a European group of clinicians and scientists focused on neuromyelitis optica spectrum disorders and myelin oligodendrocyte antibody associated disorder.

​

We meet annually to discuss projects, controversial topics and set priorities for future work.

© 2025 by Quirin Bellmann.

​

bottom of page